Aquestive Therapeutics (AQST) Experiences This autumn Loss, Tops Income Estimates

HomeInvesting

Aquestive Therapeutics (AQST) Experiences This autumn Loss, Tops Income Estimates

Aquestive Therapeutics (AQST) got here out with a quarterly lack of $0.60 per share versus the Zacks Consensus Estimate of a lack of $0.46. This compares to lack of $0.48 per share a yr in the past. These figures are adjusted for non-recurring gadgets. www.nasdaq.com



Aquestive Therapeutics (AQST) got here out with a quarterly lack of $0.60 per share versus the Zacks Consensus Estimate of a lack of $0.46. This compares to lack of $0.48 per share a yr in the past. These figures are adjusted for non-recurring gadgets.



www.nasdaq.com